These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12569483)
1. Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex. Ernst JT; Becerril J; Park HS; Yin H; Hamilton AD Angew Chem Int Ed Engl; 2003 Feb; 42(5):535-9. PubMed ID: 12569483 [No Abstract] [Full Text] [Related]
2. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL. Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929 [TBL] [Abstract][Full Text] [Related]
3. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183 [TBL] [Abstract][Full Text] [Related]
4. Design and modular parallel synthesis of a MCR derived alpha-helix mimetic protein-protein interaction inhibitor scaffold. Antuch W; Menon S; Chen QZ; Lu Y; Sakamuri S; Beck B; Schauer-Vukasinović V; Agarwal S; Hess S; Dömling A Bioorg Med Chem Lett; 2006 Mar; 16(6):1740-3. PubMed ID: 16427279 [TBL] [Abstract][Full Text] [Related]
5. Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors. Yap JL; Cao X; Vanommeslaeghe K; Jung KY; Peddaboina C; Wilder PT; Nan A; MacKerell AD; Smythe WR; Fletcher S Org Biomol Chem; 2012 Apr; 10(15):2928-33. PubMed ID: 22395339 [TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Lama D; Sankararamakrishnan R Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209 [TBL] [Abstract][Full Text] [Related]
7. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Sattler M; Liang H; Nettesheim D; Meadows RP; Harlan JE; Eberstadt M; Yoon HS; Shuker SB; Chang BS; Minn AJ; Thompson CB; Fesik SW Science; 1997 Feb; 275(5302):983-6. PubMed ID: 9020082 [TBL] [Abstract][Full Text] [Related]
8. Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry. Kutzki O; Park HS; Ernst JT; Orner BP; Yin H; Hamilton AD J Am Chem Soc; 2002 Oct; 124(40):11838-9. PubMed ID: 12358513 [TBL] [Abstract][Full Text] [Related]
9. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins. Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586 [TBL] [Abstract][Full Text] [Related]
10. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Degterev A; Lugovskoy A; Cardone M; Mulley B; Wagner G; Mitchison T; Yuan J Nat Cell Biol; 2001 Feb; 3(2):173-82. PubMed ID: 11175750 [TBL] [Abstract][Full Text] [Related]
11. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein. Yin H; Hamilton AD Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365 [TBL] [Abstract][Full Text] [Related]
12. Two-face, two-turn α-helix mimetics based on a cross-acridine scaffold: analogues of the Bim BH3 domain. Li X; Wang Z; Feng Y; Song T; Su P; Chen C; Chai G; Yang Y; Zhang Z Chembiochem; 2014 Jun; 15(9):1280-5. PubMed ID: 24838655 [TBL] [Abstract][Full Text] [Related]
13. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members. Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042 [TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics study of peptide segments of the BH3 domain of the proapoptotic proteins Bak, Bax, Bid and Hrk bound to the Bcl-xL and Bcl-2 proteins. Pinto M; Perez JJ; Rubio-Martinez J J Comput Aided Mol Des; 2004 Jan; 18(1):13-22. PubMed ID: 15143800 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412 [TBL] [Abstract][Full Text] [Related]
16. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members. Santiveri CM; Sborgi L; de Alba E J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964 [TBL] [Abstract][Full Text] [Related]
18. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins. Zhang S; Long A; Link AJ ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain. Boersma MD; Haase HS; Peterson-Kaufman KJ; Lee EF; Clarke OB; Colman PM; Smith BJ; Horne WS; Fairlie WD; Gellman SH J Am Chem Soc; 2012 Jan; 134(1):315-23. PubMed ID: 22040025 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the anti-apoptotic mechanism of Bcl-B. Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]